转换到繁體中文
您的位置 : 首页 > 报刊

益智复方汤的化学成分研究(Ⅱ)
作者:孙连娜 李霞 杨颖博 张汉明 陈万生    
作者单位:中国人民解放军第二军医大学药学院,上海 200433;中国人民解放军第二军医大学 现代中药研究中心,上海 200433;中国人民解放军第二军医大学长征医院,上海 200003

《时珍国医国药》 2009年 第3期

  多个检索词,请用空格间隔。
       【摘要】 
       的对益智复方汤中的化学成分进行系统研究。方法利用大孔吸附树脂、聚酰胺、硅胶柱层析和中压制备等手段进行分离,依据理化性质和波谱法鉴定化学结构。结果从益智复方汤的大孔吸附树脂50%洗脱部分分得10个化合物,分别鉴定为人参皂苷Rb1 ①,人参皂苷Rb2 ②,人参皂苷Rb3 ③,人参皂苷Rc④,人参皂苷Rd⑤,人参皂苷Rf⑥,人参皂苷Rg2⑦,箭藿苷A⑧,箭藿苷B⑨和2″-O-a-L-鼠李吡喃糖基淫羊藿次苷II⑩。结论以上化合物均为首次从益智复方汤中分得,其中化合物①~⑦来源于红参;化合物⑧~⑩来源于淫羊藿。
       【关键词】  益智复方汤 化学成分
       益智复方汤主要由何首乌、红参和淫羊藿等药材合煎而得,为一临床验方,具有益肾助阳、补气安神、益智养精之功效。药理实验表明其具有显著防治老年性痴呆(又称阿尔茨海默病,Alzheimer"s disease AD)的疗效[1~3]。在进行益智复方防治AD药效学研究的同时,为阐明益智复方的药效物质基础,作者对其化学成分进行了较为系统的研究。本研究报道从复方水煎剂大孔吸附树脂50%洗脱部分分得10个化合物,即人参皂苷Rb1 ①,人参皂苷Rb2 ②,人参皂苷Rb3 ③,人参皂苷Rc④,人参皂苷Rd⑤,人参皂苷Rf⑥,人参皂苷Rg2⑦,箭藿苷A⑧,箭藿苷B⑨和2″-O-a-L-鼠李吡喃糖基淫羊藿次苷II⑩的分离和结构鉴定。化合物①~⑦的结构如图1,化合物⑧~⑩的结构如图2。
       1  仪器与材料
       
       日本Yanaco显微熔点测定仪(温度计未校正);日立275-50红外分析仪(KBr压片);Bruker-Spectrospin AC-300P型核磁共振仪及Bruker AMX-500型核磁共振仪;Varian MAT-212型质谱仪。低压柱色谱硅胶H(青岛海洋化工厂);sephadex LH-20(Pharmacia公司);ODSRP-18(Merk公司);大孔吸附树脂1300型(上海医药工业研究院);聚酰胺(中国医药集团上海化学试剂公司)。中压制备系统:FMI LAB泵,lobar-C18中压反相柱。HPTLC板(烟台市化工研究院);试剂均为分析纯。
       ①R1为 glc-2glc-     R2为 H   R3为glc-6glc-
       
       ②R1为 glc-2glc-     R2为 H  R3为ara(p)-6glc-
       
       ③R1为 glc-2glc-       R2为 H    R3为xyl-6glc-
       
       ④R1为 glc-2glc-       R2为 H     R3为ara(f)-6glc-
       
       ⑤R1为 glc-2glc-     R2为 H     R3为glc-
         
       ⑥R1为 H  R2为 glc-2glc-O     R3为H
       
       ⑦R1为 H  R2为 rha-2glc-O     R3为H
       
       图1  化合物①~⑦的结构(略)
       ⑧R1 为rha-2glc  R2  为 H  ⑨R1 为rha-2xyl  R2  为 H
       ⑩R1 为rha-2rha-   R2  为 H
       
       图2  化合物⑧~⑩的结构(略)
       
       何首乌购自广东德庆,晒干,粉碎,过14目筛;红参(80支)购自吉林靖宇,切制成约0.3 cm厚的纵切片,阴干;淫羊藿购自四川成都,切制成约10 cm左右的长段;3种药材经上海第二军医大学陈万生教授鉴定分别为蓼科植物何首乌Polygonum multiflorum Thunb.的干燥块根;五加科植物人参Panax ginseng C. A. Mey.的栽培品经蒸制后的干燥根;小檗科植物巫山淫羊藿Epimedium wushanense T. S. Ying的干燥地上部分,符合2005年版《中国药典》(Ⅰ部)标准,标本存放于第二军医大学药学院生药学教研室。
       2  方法与结果
       2.1  提取和分离  取何首乌粗粉,红参厚片,淫羊藿长段按比例混合(合计21 kg),加水浸泡,待药材充分吸水后,水蒸气热提,提取3次,2 h/次,煎煮液合并浓缩至适当体积后用二氯甲烷萃取,回收溶剂后得二氯甲烷部分。应用大鼠东莨菪碱学习记忆障碍模型进行防治AD活性筛选结果表明,二氯甲烷部分活性较弱。水部分(2.58 kg)过1300型大孔吸附树脂,水-乙醇梯度洗脱,得水、10%,30%,50%,70%,95%乙醇各部分。50%乙醇洗脱部分(214 g)经反复低压硅胶柱层析,Sephadex LH-20、ODSRP-18、聚酰胺及中压制备,分离得到化合物①(33 mg),② (16 mg),③ (14 mg),④ (15 mg),⑤ (27 mg),⑥(13 mg),⑦ (15 mg),⑧ (14 mg),⑨ (16 mg),⑩(46 mg)。
       2.2  结构鉴定
       2.2.1  化合物1  白色结晶性粉末(H2O),mp 196~200 ℃,Liebermann- Burchard和Molish反应均呈阳性。ESI-MS:1 107[M-H]-。1H-NMR(吡啶-d5) δ:5.36(1H,d,J = 7.0 Hz,3-O-G- H -1″), 5.12(1H,d,J = 7.0 Hz,3-O-G- H -1′),4.91(1H,d,J = 7.0 Hz,20-O-G-H-1′),5.09(1H,s,20-O-G-H-1″);5.32(1H,t,J = 6.0 Hz,H-24)。13C-NMR-DEPT(吡啶-d5)δ:39.3 (C-1),26.8 (C-2),89.0 (C-3),39.7 (C-4),56.4 (C-5),18.5 (C-6),35.2 (C-7),40.1 (C-8),50.3 (C-9),37.0 (C-10),30.8 (C-11),70.2 (C-12),49.5 (C-13),51.7 (C-14),30.9 (C-15),26.7 (C-16),51.5 (C-17),16.1 (C-18),16.3 (C-19),83.5 (C-20),22.4 (C-21),36.2 (C-22),23.2 (C-23),126.0 (C-24),131.1 (C-25),25.8 (C-26),18.0 (C-27),28.1 (C-28),16.6 (C-29),17.5 (C-30);105.1 (3-O-G-C-1′),83.5 (3-O-G-C-2′),78.0 (3-O-G-C-3′),71.8 (3-O-G-C-4′),78.4 (3-O-G-C-5′),62.9 (3-O-G-C-6′),106.1 (3-O-G-C-1″),77.2 (3-O-G-C-2″),79.3 (3-O-G-C-3″),71.7 (3-O-G-C-4″),78.4 (3-O-G-C-5″),62.8 (6-O-G-C-6″),98.1 (20-O-G-C-1′),75.3 (20-O-G-C-2′),78.4 (20-O-G-C-3′),71.7 (20-O-G-C-4′),77.1 (20-O-G-C-5′),70.3 (20-O-G-C-6′),105.4 (20-O-G-C-1″),74.9(20-O-G-C-2″),78.3 (20-O-G-C-3″),71.6 (20-O-G-C-4″),78.1 (20-O-G-C-5″),62.8 (20-O-G-C-6″)。以上数据与文献报道[4]的20(S)-人参皂苷-Rb1 (ginsenoside Rb1)数据一致。
       2.2.2  化合物2  白色结晶性粉末(CH3OH-H2O),mp 199~201 ℃。Liebermann-Burchard和Molish反应均呈阳性。ESI-MS:1 077 (M+-1)。1H-NMR(吡啶-d5)δ:5.37 (1H,d,J = 8.0 Hz,3-O-G-H-1″), 5.12 (1H,d,J = 8.0 Hz,3-O-G-H-1′),4.99 (1H,d,J = 6.0 Hz,20-O-G-H-1"-),4.92 (1H,s,20-O-A-H-1″),5.32 (1H,t,J = 6.0 Hz,H-24)。13C-NMR-DEPT(吡啶-d5)δ:38.9 (C-1),26.4 (C-2),88.6 (C-3),39.4 (C-4),56.1 (C-5),18.1 (C-6),34.8 (C-7),39.7 (C-8),49.9 (C-9),36.6 (C-10),30.4 (C-11),69.8 (C-12),49.1 (C-13),51.1 (C-14),30.5 (C-15),26.3 (C-16),51.3 (C-17),15.7 (C-18),15.9 (C-19),83.1 (C-20),22.0 (C-21),35.8 (C-22),22.9 (C-23),125.6 (C-24),130.7 (C-25),25.4 (C-26),17.5 (C-27),27.8 (C-28),16.2 (C-29),17.0 (C-30);104.7 (3-O-G-C-1′),83.2 (3-O-G-C-2′),77.7 (3-O-G-C-3′),71.5 (3-O-G-C-4′),77.6 (3-O-G-C-5′),62.6 (3-O-G-C-6′),105.7 (3-O-G-C-1″),76.8 (3-O-G-C-2″),78.5 (3-0-G-C-3″),71.4 (3-O-G-C-4″), 77.9 (3-O-G-C-5″),62.4 (6-O-G-C-6″),97.8 (20-O-G-C-1′),74.6 (20-O-G-C-2′),78.0 (20-O-G-C-3′),71.4 (20-O-G-C-4′),76.4 (20-O-G-C-5′),68.8 (20-O-G-C-6′),104.2 (20-O-A-C-1″),71.8 (20-O-A-C-2″),73.7 (20-O-A-C-3″),68.1 (20-O-C-A-4″),65.1 (20-O-A-C-5″)。以上数据与文献报道[4]的20(S)-人参皂苷-Rb2 (ginsenoside Rb2)数据一致。
       2.2.3  化合物3  白色结晶性粉末(CH3OH-H2O) ,mp 195~198 ℃,Liebermann-Burchard和Molish反应均呈阳性。ESI-MS:1 077 (M+-1)。1H-NMR(吡啶-d5)δ:5.37 (1H,d,J = 7.0 Hz,3-O-G-H-1″),5.14 (1H,d,J = 8.0 Hz,3-O-G-H-1′),4.98 (1H,d,J = 7.0 Hz,20-O-G-H-1′),4.72 (1H,d,J = 10 Hz,20-O-X-H-1″);5.33 (1H,t,J = 7.0 Hz,H-24)。13C-NMR-DEPT(吡啶-d5)δ:38.8 (C-1),26.4 (C-2),88.6 (C-3),39.3 (C-4),56.0 (C-5),18.1 (C-6),34.8 (C-7),39.7 (C-8),49.8 (C-9),36.5 (C-10),30.5 (C-11),69.7 (C-12),49.1 (C-13),51.0 (C-14),30.3 (C-15),26.3 (C-16),51.2 (C-17),15.6 (C-18),15.9 (C-19),83.1 (C-20),21.9 (C-21),35.8 (C-22),22.8 (C-23),125.6 (C-24),130.2 (C-25),25.4 (C-26),17.5 (C-27),27.7 (C-28),16.2 (C-29),17.0 (C-30);104.7 (3-O-G-C-1′),83.2 (3-O-G-C-2′),77.6 (3-O-G-C-3′),71.3 (3-O-G-C-4′),77.6 (3-O-G-C-5′),62.5 (3-O-G-C-6′),105.7 (3-O-G-C-1″),76.8 (3-O-G-C-2″),78.0 (3-O-G-C-3″),71.3 (3-O-G-C-4″), 77.9 (3-O-G-C-5″),62.3 (3-O-G-C-6″) ,97.7 (20-O-G-C-1′),74.5 (20-O-G-C-2′),77.7 (20-O-G-C-3′),71.3 (20-O-G-C-4′),76.5 (20-O-G-C-5′),69.7 (20-O-G-C-6′),105.4 (20-O-X-C-1″),74.5 (20-O-X-C-2″),78.9 (20-O-X-C-3″),70.7 (20-O-X-C-4″),66.6 (20-O-X-C-5″)。以上数据与文献报道[4]的20(S)-人参皂苷-Rb3 (ginsenoside Rb3)数据一致。
       2.2.4  化合物4  白色结晶性粉末(CH3OH-H2O),mp 202~205 ℃。Liebermann-Burchard和Molish反应均呈阳性。ESI-MS:1 077 (M+-1)。1H-NMR(吡啶-d5)δ:5.34 (1H,d,J = 8.0 Hz,3-O-G-H-1″),5.11 (1H,d,J = 8.0 Hz,3-O-G-H-1′),4.91 (1H,d,J = 7.0 Hz,20-O-G-H-1′),5.60 (1H,s,20-O-A-1″-H);5.41 (1H,t,J = 6.0 Hz,H-24)。13C-NMR-DEPT(吡啶-d5)δ:38.8 (C-1),26.4 (C-2),88.6 (C-3),39.3 (C-4),56.0 (C-5),18.1 (C-6),34.8 (C-7),39.7 (C-8),49.8 (C-9),36.5 (C-10),30.6 (C-11),69.9 (C-12),49.1 (C-13),51.0 (C-14),30.4 (C-15),26.3 (C-16),51.3 (C-17),15.6 (C-18),15.9 (C-19),83.0 (C-20),22.0 (C-21),35.8 (C-22),22.8 (C-23),125.6 (C-24),130.6 (C-25),25.4 (C-26),17.5 (C-27),27.7 (C-28),16.2 (C-29),17.0 (C-30);104.7 (3-O-G-C-1′),82.9 (3-O-G-C-2′),77.7 (3-O-G-C-3′),71.8 (3-O-G-C-4′),77.6 (3-O-G-C-5′),62.5 (3-O-G-C-6′),105.7 (3-O-G-C-1″),76.8 (3-O-G-C-2″),78.5 (3-O-G-C-3″),71.3 (3-O-G-C-4″), 78.0 (3-O-G-C-5″),62.4 (6-O-G-C-6″) ,97.7 (20-O-G-C-1′),74.8 (20-O-G-C-2′),77.9 (20-O-G-C-3′),71.3 (20-O-G-C-4′),76.2 (20-O-G-C-5′),68.1 (20-O-G-C-6′), 109.8 (20-O-A-C-1″),83.1 (20-O-A-C-2″),78.9 (20-O-A-C-3″),85.7 (20-O-A-C-4″),62.4 (20-O-A-C-5″)。以上数据与文献报道[4]的20(S)-人参皂苷-Rc (ginsenoside Rc)数据一致。
       2.2.5  化合物5  白色结晶性粉末(CH3OH-H2O),mp 204~207 ℃。Liebermann-Burchard和Molish反应均呈阳性。ESI-MS:945 (M+-1)。1H-NMR(吡啶-d5)δ:5.36 (1H,d,J = 8.0 Hz,3-O-G-H-1″), 5.16 (1H,d,J = 8.0 Hz,3-O-G-H-1′),4.91 (1H,20-O-G-H-1′);5.23 (1H,t,J = 7.0 Hz, H-24)。13C-NMR-DEPT(吡啶-d5)δ:38.8 (C-1),26.4 (C-2),88.6 (C-3),39.3 (C-4),56.0 (C-5),18.1 (C-6),34.8 (C-7),39.7 (C-8),49.8 (C-9),36.5 (C-10),30.6 (C-11),69.8 (C-12),49.1 (C-13),51.1 (C-14),30.4 (C-15),26.3 (C-16),51.3 (C-17),15.6 (C-18),15.9 (C-19),82.9 (C-20),22.0 (C-21),35.8 (C-22),22.8 (C-23),125.6 (C-24),130.5 (C-25),25.4 (C-26),17.4 (C-27),27.7 (C-28),16.2 (C-29),17.0 (C-30);104.7 (3-O-G-C-1′),83.1 (3-O-G-C-2′),78.0 (3-O-G-C-3′),71.3 (3-O-G-C-4′),77.9 (3-O-G-C-5′),62.5 (3-O-G-C-6′),105.7 (3-O-G-C-1″),76.8 (3-O-G-C-2″),78.9 (3-O-G-C-3″),71.3 (3-O-G-C-4″), 77.9 (3-O-G-C-5″),62.5 (6-O-G-C-6″) ,97.9 (20-O-G-C-1′),74.8 (20-O-G-C-2′),77.7 (20-O-G-C-3′),71.3 (20-O-G-C-4′),77.6 (20-O-G-C-5′),62.4 (20-O-G-C-6′)。以上数据与文献报道[5]的20(S)-人参皂苷-Rd (ginsenoside Rd)数据一致。
       2.2.6  化合物6  白色结晶性粉末(CH3OH-H2O),mp 190~193 ℃。Liebermann-Burchard和Molish反应均呈阳性。ESI-MS:799 (M+-1)。1H-NMR(吡啶-d5) δ:5.91 (1H,d,J = 7.0 Hz,G-H-1″), 4.94 (1H,G-H-1′); 5.33 (1H,t,J = 7.0 Hz,24-H),3.48 (1H,dd,J = 5,12 Hz,H -3α)。13C-NMR-DEPT(吡啶-d5)δ:39.0 (C-1),27.4 (C-2),77.52 C-3),39.8 (C-4),61.0 (C-5),78.2 (C-6),44.6 (C-7),39.2 (C-8),49.7 (C-9),40.8 (C-10),30.9 (C-11),70.6 (C-12),47.9 (C-13),51.3 (C-14),31.0 (C-15),26.4 (C-16),54.4 (C-17),17.2 (C-18),17.0 (C-19),72.6 (C-20),26.6 (C-21),35.4 (C-22),22.6 (C-23),125.9 (C-24),130.4 (C-25),25.4 (C-26),17.3 (C-27),31.7 (C-28),16.4 (C-29),16.4 (C-30);103.5 (6-O-G-C-1′),79.2 (6-O-G-C-2′),78.1 (6-O-G-C-3′),71.9 (6-O-G-C-4′),79.5 (6-O-G-C-5′),63.0 (6-O-G-C-6′),103.5 (6-O-G-C-1″),71.9 (6-O-G-C-2″),77.7 (6-O-G-C-3″),71.3 (6-O-G-C-4″),79.5 (6-O-G-C-5″),62.5 (6-O-G-C-6″)。以上数据与文献报道[4]的20(S)-人参皂苷-Rf(ginsenoside Rf)数据一致。
       2.2.7  化合物7白色结晶性粉末(CH3OH-H2O),mp 183~185 ℃。Liebermann-Burchard和Molish反应均呈阳性。ESI-MS:783 (M+-1)。1H-NMR(吡啶-d5)δ:6.47 (1H,br s,R-H-1″), 5.26 (1H,d,J = 7.0 Hz,G-H-1′);5.34 (1H,t,J = 7.0 Hz,H-24),3.48 (1H,dd,J = 5,12 Hz,H-3α);4.51 (1H,dd,J = 2,12 Hz,H -6β),4.21 (1H,t,J = 8.5 Hz,H -12α)。 13C-NMR-DEPT(吡啶-d5)δ:39.0 (C-1),27.4 (C-2),78.0 (C-3),39.6 (C-4),60.5 (C-5),74.0 (C-6),45.7 (C-7),39.0 (C-8),49.4 (C-9),40.8 (C-10),31.7 (C-11),70.7 (C-12),47.9 (C-13),51.3 (C-14),31.0 (C-15),26.5 (C-16),54.3 (C-17),17.3 (C-18),17.2 (C-19),72.3 (C-20),26.7 (C-21),35.4 (C-22),22.6 (C-23),126.0 (C-24),130.4 (C-25),25.5 (C-26),16.6 (C-27),31.8 (C-28),17.3 (C-29),16.8 (C-30);101.6 (6-O-G-C-1′),79.0 (6-O-G-C-2′),78.2 (6-O-G-C-3′),72.3 (6-O-G-C-4′),78.0 (6-O-G-C-5′),62.8 (6-O-G-C-6′),101.4 (6-O-R-C-1″),71.9 (6-O-R-C-2″),72.1 (6-O-R-C-3″),73.8 (6-O-R-C-4″),69.1 (6-O-R-C-5″),18.4 (6-O-R-C-6″)。以上数据与文献报道[6]的20(S)-人参皂苷-Rg2 (ginsenoside Rg2)数据一致。
       2.2.8  化合物8  黄色粉末(CH3OH-H2O),mp 170~172 ℃。盐酸-镁粉反应和Molish反应均呈阳性。ESI-MS:675 (M+-1)。1H-NMR(DMSO-d6)δ:5.54 (1H,br s,3-O-R-H-1′),4.24 (1H,d,J = 8.0 Hz,3-O-G-H-1″);7.99 (2H,d,J = 8.0 Hz,H "-2"、6′),7.13 (2H,d,J = 8.0 Hz,H -3"、5′),6.33 (1H,s,H-6′),5.16 (1H,t,H-12),3.95 (3H,s,4"-OCH3)。13C-NMR-DEPT(DMSO-d6)δ:156.4 (C-2),134.7 (C-3),177.8 (C-4),161.3 (C-5),98.3 (C-6),161.8 (C-7),106.0 (C-8),153.8 (C-9),104.0 (C-10),21.1 (C-11),122.3 (C-12),130.9 (C-13),17.7 (C-14),25.4 (C-15),122.3 (C-1′),130.3 (C-2′),114.1 (C-3′),158.5 (C-4′),114.1 (C-5′),130.3 (C-6′),55.4 (4"-OCH3);101.0 (3-O-R-C-1′),81.2 (3-O-R-C-2′),70.3 (3-O-R-C-3′),71.5 (3-O-R-C-4′),70.0 (3-O-R-C-5′),17.3 (3-O-R-C-6′),106.0 (3-O-G-C-1″),73.7 (3-O-G-C-2″),76.1 (3-O-G-C-3″),69.2 (3-O-G-C-4″), 76.6 (3-O-G-C-5″),60.4 (3-O-G-C-6″) 以上数据与文献报道[8]的箭藿苷A (sagittatoside A)数据一致。
       2.2.9  化合物9  黄色粉末(CH3OH-H2O),mp 161~162 ℃。盐酸-镁粉反应和Molish反应均呈阳性。ESI-MS:645 (M+-1)。1H-NMR(DMSO-d6)δ:5.36 (1H,s,3-O-R-H-1′),4.22 (1H,d,J = 7.0 Hz,3-O-X-H-1″); 7.90 (2H,d,J = 9.0 Hz,H -2"、6′),7.12 (2H,d,J = 9.0 Hz,H- 3"、5′),6.31 (1H,s,H-6),5.17 (1H,br,H -12),3.88 (3H,s,4"-OCH3), 1.69(3H, s,14-CH3),1.63.(3H,s,15-CH3)。13C-NMR-DEPT(DMSO-d6)δ:156.5 (C-2),134.5 (C-3),178.2 (C-4),161.4 (C-5),98.3 (C-6),161.5 (C-7),106.3 (C-8),153.3 (C-9),104.7 (C-10),21.3 (C-11),122.1 (C-12),131.2 (C-13),17.6 (C-14),25.0 (C-15),122.2 (C-1′),130.4 (C-2′),114.1 (C-3′),159.0 (C-4′),114.1 (C-5′),130.4 (C-6′) ,55.7 (4"-OCH3); 101.2 (3-O-R-C-1′),80.9 (3-O-R-C-2′),70.5 (3-O-R-C-3′),71.8 (3-O-R-C-4′),69.5 (3-O-R-C-5′),17.5 (3-O-R-C-6′),106.1 (3-O-X-C-1″),73.8 (3-O-X"-C-2″),76.3 (3-O-X-C-3″),70.7 (3-O-X-C-4″),65.8 (3-O-X-C-5″)。以上数据与文献报道[7]的箭藿苷B (sagittatoside B)数据一致。
       2.2.10  化合物10  黄色粉末(CH3OH-H2O),mp 162~164 ℃。盐酸-镁粉反应和Molish反应均呈阳性,ESI-MS:659 (M+-1)。1H-NMR(DMSO-d6)δ:5.37 (1H,br s,3-O-R-H-1′),4.89 (1H,s,3-O-R-H-1″); 7.89 (2H, d, J = 9.0 Hz,H- 2"、6′),7.14 (2H, d, J = 9.0 Hz,H -3"、5′),6.32 (1H,s,H-6),5.14 (1H,br,H-12),3.84(3H,s,4"-OCH3)。13C-NMR-DEPT(DMSO-d6)δ:157.0 (C-2),134.6 (C-3),170.0 (C-4),160.5 (C-5),98.2 (C-6),161.2 (C-7),108.5 (C-8),152.9 (C-9),105.2 (C-10),21.3 (C-11),121.9 (C-12),131.3 (C-13),17.7 (C-14),25.5 (C-15),122.3 (C-1′),130.4 (C-2′),113.8 (C-3′),158.9 (C-4′),113.8 (C-5′),130.4 (C-6′) ,55.4 (4"-OCH3);100.7 (3-O-R-C-1′),75.6 (3-O-R-C-2′),70.6 (3-O-R-C-3′),71.9 (3-O-R-C-4′),70.2 (3-O-R-C-5′),17.6 (3-O-R-C-6′),101.4 (3-O-R-C-1″),70.3 (3-O-R-C-2″),70.8 (3-O-R-C-3″),71.4 (3-O-R-C-4″),68.8 (3-O-R-C-5″),17.35(3-O-R-C-6″)。以上数据与文献报道[8]的2″-O-a-L-鼠李吡喃糖基淫羊藿次苷II(2″-O-a-L -rhamnosyl-icariside II)数据一致。
       3  讨论
       
       本研究运用多种分离纯化手段,从益智复方汤的大孔吸附树脂50%洗脱部分分得10个化合物,并对其进行结构鉴定,为益智复方汤的药效物质基础的初步研究提供了依据。
       【参考文献】
          [1] 吴航宇,李 琳,徐江平,等.益智复方对学习记忆障碍模型的影响及β淀粉样肽细胞毒性的保护作用[J].中药材,2003,26(7):495.
       
       [2] Xu JP,Wu HY,Li L. Effects of compound Yi-Zhi on D-galactose-induced learning and memory deficits in mice[J]. Chin J Clin Pharmacol Ther,2003,8(1):31.
       
       [3] 吴航宇,徐江平,靳轶敏.益智复方对东莨菪碱所致学习记忆障碍模型的影响[J]. 中华临床新医学,2003,3(3):193.
       
       [4] 王本祥.人参研究进展83-88[M] .天津:天津科学技术出版社,1991:29.
       
       [5] 腾荣伟,李海洲,王德祖,等.三七皂苷NMR研究Ⅱ:—3个原人参二醇型双糖链配糖体的NMR信号全归属[J]. 波谱学杂志,2002,19(1):25.
       
       [6] 杨秀伟.20(R)和20(S)-人参皂甙-Rg2碳氢NMR信号全指定[J].波谱学杂志,2000,17(1):10.
       
       [7] 李文魁,肖培根,张如意.朝鲜淫羊藿的化学成分研究Ⅱ[J].天然产物研究与开发,1994,5(4):13.
       
       [8] 李文魁,张如意,肖培根.朝鲜淫羊藿的化学成分研究[J]. 中草药,1995,26(9):453.

经典中医古籍

中药学教材(附图片)

穴位数据库(附图片)